After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

Two formative experiences shaped Craig Crews’ path into drug development. First, when he was still a child, his grandmother died from cancer at just 52 years old. “At the time, there weren’t very many ...

Scientists have developed a new treatment strategy that could one day save the lives of children affected by aggressive brain ...

Experimental drugs for renal and other genitourinary cancers are more likely to be approved when pharmaceutical companies collaborate on the research, according to a study in JCO Oncology Practice.

Advances in cancer research have led to an increasing number and variety of cancer therapies in the development pipeline, but there are concerns that traditional processes for drug development, ...